Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $735.9900 (1.76%) ($735.9900 - $738.1100) on Sun. Jul. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 58 | Latest Price | $735.9900(1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting REGN price | REGN will decline at least -0.88% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $725.16(1.49%) | 10 Day Moving Average | $720.55(2.14%) | 20 Day Moving Average | $721.44(2.02%) | To recent high | -8.7% | To recent low | 6.3% | Market Cap | $N/A | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |